Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Electronic Resource  (2)
  • 2000-2004
  • 1995-1999  (2)
  • 1910-1914
  • acute myocardial infarction  (2)
  • 1
    ISSN: 1573-742X
    Keywords: thrombolytic therapy ; acute myocardial infarction ; patency
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract To study the safety and efficacy of the thrombolytic agent saruplase as a bolus, the angiographic and clinical outcomes of three bolus regimens were investigated in a pilot study conducted in 192 patients with an acute myocardial infarction and were compared with the standard regimen. Fifty-two patients received a double bolus of 40 mg and 40 mg after 30 minutes, 51 patients a bolus of 80 mg, and 36 patients a bolus of 60 mg. Fifty-three patients received the standard regimen (a bolus of 20 mg and 60 mg IV infusion over 1 hour). At 60 minutes TIMI 2 and 3 flow were, respectively, 9.6% and 61.5% with the 40/40-mg bolus, 15.7% and 51.0% with the 80-mg bolus, 16.7% and 30.6% with the 60-mg bolus, and 7.5% and 54.7% with the standard 20/60-mg infusion. At 90 minutes TIMI 2 and 3 flow improved to 9.6% and 73.1%, 15.7% and 56.9%, 13.9% and 36.1%, and 5.7% and 71.7%, respectively. The primary endpoint, persistent patency (TIMI 2 + 3) at 24–45 hours, was seen in 69.2%, 64.7%, 44.4%, and 67.9% of patients who had no rescue PTCA, respectively. Inclusion in the 60-mg bolus group was prematurely stopped because of their low patency rates. The 40/40-mg bolus group had the highest mortality rate (13.5%), whereas the 60-mg bolus group had no deaths. Other adverse event rates were similar in the four groups. This clinical outcome is highly influenced by rescue PTCA of patients with insufficient TIMI flow. This pilot study indicates that in patients with an acute myocardial infarction, a double bolus of 40/40 mg resulted in the highest patency but also had the highest complication rate. The 80-mg single bolus is an attractive alternative for further evaluation because of its acceptable patency and event profile, and its easy form of administration.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    Intensivmedizin und Notfallmedizin 34 (1997), S. 266-270 
    ISSN: 1435-1420
    Keywords: Key words Coronary intervention ; PTCA ; acute myocardial infarction ; stent-implantation ; rescue-PTCA ; direct-PTCA ; primary PTCA ; Schlüsselwörter Koronarintervention ; PTCA ; akuter Myokard-infarkt ; Stent-Implantation ; Rescue-PTCA ; direkte PTCA ; primäre PTCA
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammenfassung Während die intravenöse Thrombolysetherapie weiterhin als Goldstandard der Reperfusionsbehandlung des akuten Myokardinfarktes gilt, sind in den vergangenen Jahren auch zunehmend mechanische Reperfusionsstrategien untersucht worden. Zunächst wurde das Konzept der routinemäßigen Sofort-PTCA nach Thrombolysebehandlung untersucht, das wegen einer höheren Komplikationsrate im Vergleich zur alleinigen Thrombolysetherapie jedoch keine Verbreitung fand. Beim Konzept der Rescue-PTCA erfolgt eine mechanische Rekanalisation und Dilatation nur im Falle eines dokumentierten persistierenden Gefäßverschlusses nach Thrombolysetherapie. Für dieses Konzept konnte eine verbesserte Überlebensrate und Ventrikelfunktion belegt werden. Das zuletzt untersuchte Konzept der primären PTCA, bei dem die PTCA ohne vorhergehende thrombolytische Therapie routinemäßig durchgeführt wird, zeigte im Vergleich zur Thrombolysetherapie eine signifikant geringere Letalität, Reinfarktrate und Inzidenz zerebraler Insulte. Der erhebliche logistische Aufwand steht jedoch einer weiteren Verbreitung dieser Therapieform entgegen. Gegenwärtig sollten daher mechanische Reperfusionsmaßnahmen, insbesondere bei den Patienten mit akutem Myokardinfarkt erwogen werden, bei denen eine thrombolytische Therapie kontraindiziert ist, ein kardiogener Schock vorliegt oder ein anderes Krankheitsbild differentialdiagnostisch abgegrenzt werden muß. Gegebenenfalls sollte auch bei älteren Patienten (〉75 Jahre) von einer Thrombolysebehandlung zugunsten mechanischer Reperfusionsmaßnahmen Abstand genommen werden. Nach erfolgter Thrombolysetherapie sollte bei fehlenden Reperfusionszeichen eine Herzkatheteruntersuchung und im Falle eines persistierenden Gefäßverschlusses eine mechanische Rekanalisation im Sinne der Rescue-PTCA angestrebt werden.
    Notes: Summary Although thrombolysis remains the gold standard in the treatment of acute myocardial infarction, mechanical reperfusion strategies have been introduced into the clinical routine within recent years. The concept of a routinely performed immediate PTCA following thrombolysis was combined with a higher complication rate compared to thrombolysis alone and was therefore abandoned. The concept of rescue-PTCA, where PTCA is performed only in case of persistent occlusion of the infarct-related artery, led to a better left ventricular function and higher survival rate. The relatively new concept of primary PTCA, which is performed routinely without preceding thrombolysis, revealed a significantly lower mortality, reinfarction rate and incidence of cerebral bleedings compared to thrombolysis. Currently, the following strategy for patients with acute myocardial infarction is recommended. In patients with cardiogenic shock, contraindications to thrombolysis, an unclear diagnosis or advanced age (more than 75 years) mechanical reperfusion should be the preferred strategy. In case of persistent or recurrent ischemia, electrical or hemodynamic instability following thrombolysis, coronary angiography and, in case of need, rescue-PTCA should be performed.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...